|
|
||||||||
The in vitro activities of dihydroartemisinin (the biologically active metabolite of artemisinin derivatives), chloroquine, monodesethylamodiaquine (the biologically active metabolite of amodiaquine), quinine, mefloquine, halofantrine, and pyrimethamine were assessed in 65 African isolates of Plasmodium falciparum from Yaounde, Cameroon using an isotopic microtest. The 50% inhibitory concentration (IC50) values for dihydroartemisinin were within a narrow range from 0.25 to 4.56 nM, with a geometric mean of 1.11 nM (95% confidence interval = 0.96-1.28 nM). Dihydroartemisinin was equally active (P > 0.05) against the chloroquine-sensitive isolates (geometric mean IC50 = 1.25 nM, 95% confidence interval = 0.99-1.57 nM) and the chloroquine-resistant isolates (geometric mean IC50 = 0.979 nM, 95% confidence interval = 0.816-1.18 nM). A significant positive correlation was observed between the responses to dihydroartemisinin and mefloquine (r = 0.662) or halofantrine (r = 0.284), suggesting in vitro cross-resistance. There was no correlation between the responses to dihydroartemisinin and other antimalarial drugs.
This article has been cited by other articles:
![]() |
S. NKHOMA, M. MOLYNEUX, and S. WARD IN VITRO ANTIMALARIAL SUSCEPTIBILITY PROFILE AND PRCRT/PFMDR-1 GENOTYPES OF PLASMODIUM FALCIPARUM FIELD ISOLATES FROM MALAWI Am J Trop Med Hyg, June 1, 2007; 76(6): 1107 - 1112. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. K. BASCO and P. RINGWALD MOLECULAR EPIDEMIOLOGY OF MALARIA IN CAMEROON. XXIV. TRENDS OF IN VITRO ANTIMALARIAL DRUG RESPONSES IN YAOUNDE, CAMEROON Am J Trop Med Hyg, January 1, 2007; 76(1): 20 - 26. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Karunajeewa, J. Reeder, K. Lorry, E. Dabod, J. Hamzah, M. Page-Sharp, G. M. Chiswell, K. F. Ilett, and T. M. E. Davis Artesunate Suppositories versus Intramuscular Artemether for Treatment of Severe Malaria in Children in Papua New Guinea Antimicrob. Agents Chemother., March 1, 2006; 50(3): 968 - 974. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. MESHNICK and A. P. ALKER AMODIAQUINE AND COMBINATION CHEMOTHERAPY FOR MALARIA Am J Trop Med Hyg, November 1, 2005; 73(5): 821 - 823. [Full Text] [PDF] |
||||
![]() |
D. MENARD, M. D. MATSIKA-CLAQUIN, D. DJALLE, F. YAPOU, A. MANIRAKIZA, V. DOLMAZON, J. SARDA, and A. TALARMIN ASSOCIATION OF FAILURES OF SEVEN-DAY COURSES OF ARTESUNATE IN A NON-IMMUNE POPULATION IN BANGUI, CENTRAL AFRICAN REPUBLIC WITH DECREASED SENSITIVITY OF PLASMODIUM FALCIPARUM Am J Trop Med Hyg, September 1, 2005; 73(3): 616 - 621. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. MENARD, D. DJALLE, A. MANIRAKIZA, F. YAPOU, V. SIADOUA, S. SANA, M. D. MATSIKA-CLAQUIN, M. NESTOR, and A. TALARMIN DRUG-RESISTANT MALARIA IN BANGUI, CENTRAL AFRICAN REPUBLIC: AN IN VITRO ASSESSMENT Am J Trop Med Hyg, August 1, 2005; 73(2): 239 - 243. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |